Scott C Chappel

This inventor holds 29 USPTO granted patents and 14 published patent applications, plus 2 CIPO patents and 3 EPO patents, primarily in Antibody Therapeutics. Top assignees: Applied Research Systems Ars Holding N.v., Surface Oncology, Inc., Genzyme Corporation. Active years: 1992-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Scott C Chappel. Retrieved from https://idiyas.com/inventor/scott-c-chappel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 29 (Patent Applications = 14)

% Patents Active = 82.8

CIPO Patents = 2

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 2.4

ph-index = 7

Forward Citations = 422(Granted Patents)

Location History:

Jamaica Plain, MA (US) (1993)
Boston, MA (US) (1992 - 1999)
Cambridge, MA (US) (2022)
Milton, MA (US) (1997 - 2023)

Company Filing History:

12 out of 156

Applied Research Systems Ars Holding N.v.

patents

9 out of 13

Surface Oncology, Inc.

Erasmus University Medical Center

Laboratoires Serono S.a.

where one patent can have more than one assignee

Years Active: 1992-2026

Loading Chart...

Areas of Expertise:

Anti-IL-27 Antibodies

Anti-CD39 Antibodies

Hybrid Heterodimeric Proteins

Glycoprotein Hormones

Heteropolymeric Protein

Site-Directed Mutagenesis

Recombinant Proteins

Ovulation Induction

Human Growth Hormone

Mammalian Systems

Protein Production

Surface Antigens

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12630624 - ANTI-IL-27 ANTIBODIES AND USES THEREOF (2026-05-19),

2. 12358978 - Anti-IL-27 antibodies and uses thereof (2025-07-15),

3. 11655303 - Anti-CD39 antibody compositions and methods (2023-05-23),

4. 11332524 - Anti-IL-27 antibodies and uses thereof (2022-05-17),

5. 11312783 - Antibody molecules to CD73 and uses thereof (2022-04-26),

6. 10793637 - Antibodies that bind CD39 and uses thereof (2020-10-06),

7. 10738128 - Antibodies that bind CD39 and uses thereof (2020-08-11),

8. 10570201 - Anti-CD47 antibodies and methods of use (2020-02-25),

9. 10442858 - Anti-CD47 antibodies and methods of use (2019-10-15),

10. 9803016 - Anti-CD47 antibodies and methods of use (2017-10-31),

11. 7291339 - Homogeneity and secretion of a recombinant follicle stimulating hormone (FSH) in mammalian systems (2007-11-06),

12. 6663867 - Hybrid heterodimeric protein hormone comprising a TNF binding protein and a glycoprotein hormone subunit and method of using same (2003-12-16),

13. 6348444 - Human growth hormone to stimulate hematopoiesis and immune reconstitution after hematopoietic stem cell transplantation in humans (2002-02-19),

14. 6194177 - DNA encoding a hybrid heterodimeric protein (2001-02-27),

15. 6193972 - Hybrid heterodimeric protein hormone (2001-02-27),

Title: Scott C Chappel - Innovator from Boston, MA

Introduction: Scott C Chappel is a renowned inventor based in Boston, MA, known for his groundbreaking contributions to various fields.

Latest Patents: Scott C Chappel holds several patents in the areas of technology and healthcare, showcasing his innovative mindset and problem-solving abilities.

Career Highlights: With a career spanning over two decades, Scott C Chappel has worked with leading research institutions and companies to develop cutting-edge solutions that have had a significant impact on society.

Collaborations: Throughout his career, Scott C Chappel has collaborated with top universities and tech companies, fostering a culture of innovation and pushing the boundaries of what is possible.

Conclusion: Scott C Chappel's passion for innovation and his dedication to creating a better future through his inventions make him a standout figure in the world of inventors.

Profile summary based on public USPTO records.